| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ANO4 SCN10A CACNA1A CACNA1C CACNA1D PKD2L1 SLC45A2 CACNA1G CACNG5 SLC30A5 ABCC2 SLC11A1 SLC12A1 SLC12A2 PKD2L2 SLC24A4 | 1.62e-12 | 758 | 43 | 16 | GO:0015318 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SCN10A CACNA1A CACNA1C CACNA1D PKD2L1 CACNA1G CACNG5 SLC30A5 SLC11A1 SLC12A1 SLC12A2 PKD2L2 SLC24A4 | 9.71e-12 | 465 | 43 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ANO4 SCN10A CACNA1A CACNA1C CACNA1D PKD2L1 SLC45A2 CACNA1G ABCA1 CACNG5 SLC30A5 ABCC2 SLC11A1 SLC12A1 SLC12A2 PKD2L2 SLC24A4 SLC22A5 | 1.01e-11 | 1180 | 43 | 18 | GO:0022857 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SCN10A CACNA1A CACNA1C CACNA1D PKD2L1 SLC45A2 CACNA1G CACNG5 SLC30A5 SLC11A1 SLC12A1 SLC12A2 PKD2L2 SLC24A4 | 2.65e-11 | 627 | 43 | 14 | GO:0022890 |
| GeneOntologyMolecularFunction | transporter activity | ANO4 SCN10A CACNA1A CACNA1C CACNA1D PKD2L1 SLC45A2 CACNA1G ABCA1 CACNG5 SLC30A5 ABCC2 SLC11A1 SLC12A1 SLC12A2 PKD2L2 SLC24A4 SLC22A5 | 4.36e-11 | 1289 | 43 | 18 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ANO4 SCN10A CACNA1A CACNA1C CACNA1D PKD2L1 SLC45A2 CACNA1G CACNG5 SLC30A5 SLC11A1 SLC12A1 SLC12A2 PKD2L2 SLC24A4 | 4.54e-11 | 793 | 43 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SCN10A CACNA1A CACNA1C CACNA1D PKD2L1 SLC45A2 CACNA1G CACNG5 SLC30A5 SLC11A1 SLC12A1 SLC12A2 PKD2L2 SLC24A4 | 5.67e-11 | 664 | 43 | 14 | GO:0008324 |
| GeneOntologyMolecularFunction | calcium channel activity | CACNA1A CACNA1C CACNA1D PKD2L1 CACNA1G CACNG5 PKD2L2 SLC24A4 | 2.92e-10 | 129 | 43 | 8 | GO:0005262 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | CACNA1A CACNA1C CACNA1D PKD2L1 CACNA1G CACNG5 PKD2L2 SLC24A4 | 1.03e-09 | 151 | 43 | 8 | GO:0015085 |
| GeneOntologyMolecularFunction | channel activity | ANO4 SCN10A CACNA1A CACNA1C CACNA1D PKD2L1 CACNA1G CACNG5 SLC12A2 PKD2L2 SLC24A4 | 1.00e-08 | 525 | 43 | 11 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | ANO4 SCN10A CACNA1A CACNA1C CACNA1D PKD2L1 CACNA1G CACNG5 SLC12A2 PKD2L2 SLC24A4 | 1.02e-08 | 526 | 43 | 11 | GO:0022803 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.84e-08 | 14 | 43 | 4 | GO:0008331 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | ANO4 SCN10A CACNA1A CACNA1C CACNA1D PKD2L1 CACNA1G CACNG5 PKD2L2 SLC24A4 | 3.63e-08 | 459 | 43 | 10 | GO:0005216 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | SCN10A CACNA1A CACNA1C CACNA1D PKD2L1 CACNA1G CACNG5 PKD2L2 SLC24A4 | 3.95e-08 | 343 | 43 | 9 | GO:0005261 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 4.68e-08 | 46 | 43 | 5 | GO:0005245 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 9.27e-08 | 5 | 43 | 3 | GO:0086007 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.91e-07 | 334 | 43 | 8 | GO:0022836 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC45A2 ABCA1 SLC30A5 ABCC2 SLC11A1 SLC12A1 SLC12A2 SLC24A4 SLC22A5 | 6.44e-07 | 477 | 43 | 9 | GO:0022804 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.69e-06 | 171 | 43 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 2.43e-06 | 182 | 43 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 2.59e-06 | 184 | 43 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 2.99e-06 | 296 | 43 | 7 | GO:0015291 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved SA node cell action potential | 4.53e-06 | 2 | 43 | 2 | GO:0086059 | |
| GeneOntologyMolecularFunction | potassium:sodium symporter activity | 1.36e-05 | 3 | 43 | 2 | GO:0009674 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in AV node cell action potential | 1.36e-05 | 3 | 43 | 2 | GO:0086056 | |
| GeneOntologyMolecularFunction | sodium:potassium:chloride symporter activity | 1.36e-05 | 3 | 43 | 2 | GO:0008511 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | ADGRB3 TAS2R42 OR5H14 OR4C13 OR52K1 ADGRF4 OR5AC2 OR52K2 ADGRL3 OR5H6 | 1.39e-05 | 884 | 43 | 10 | GO:0004930 |
| GeneOntologyMolecularFunction | symporter activity | 1.71e-05 | 150 | 43 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.82e-05 | 152 | 43 | 5 | GO:0022843 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | ADGRB3 PKD2L1 TAS2R42 OR5H14 OR4C13 OR52K1 ADGRF4 ABCA1 OR5AC2 OR52K2 ADGRL3 OR5H6 | 1.91e-05 | 1353 | 43 | 12 | GO:0004888 |
| GeneOntologyMolecularFunction | alpha-actinin binding | 4.01e-05 | 31 | 43 | 3 | GO:0051393 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 4.26e-05 | 301 | 43 | 6 | GO:0022853 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 1.08e-04 | 43 | 43 | 3 | GO:0140828 | |
| GeneOntologyMolecularFunction | actinin binding | 1.08e-04 | 43 | 43 | 3 | GO:0042805 | |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 1.62e-04 | 9 | 43 | 2 | GO:0015379 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 1.62e-04 | 9 | 43 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 1.62e-04 | 9 | 43 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.91e-04 | 52 | 43 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 3.03e-04 | 431 | 43 | 6 | GO:0004984 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 4.52e-04 | 167 | 43 | 4 | GO:0015079 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 4.94e-04 | 171 | 43 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 6.04e-04 | 17 | 43 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 7.57e-04 | 19 | 43 | 2 | GO:0015373 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 1.11e-03 | 23 | 43 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.42e-03 | 26 | 43 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 1.42e-03 | 26 | 43 | 2 | GO:0015296 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 1.54e-03 | 27 | 43 | 2 | GO:0051139 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 2.14e-03 | 119 | 43 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | taste receptor activity | 2.29e-03 | 33 | 43 | 2 | GO:0008527 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 2.43e-03 | 34 | 43 | 2 | GO:0042910 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 2.46e-03 | 125 | 43 | 3 | GO:0015108 | |
| GeneOntologyMolecularFunction | odorant binding | 2.58e-03 | 127 | 43 | 3 | GO:0005549 | |
| GeneOntologyMolecularFunction | antiporter activity | 3.26e-03 | 138 | 43 | 3 | GO:0015297 | |
| GeneOntologyMolecularFunction | transition metal ion transmembrane transporter activity | 4.05e-03 | 44 | 43 | 2 | GO:0046915 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 4.19e-03 | 151 | 43 | 3 | GO:0008509 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 5.00e-03 | 49 | 43 | 2 | GO:0140359 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 5.40e-03 | 51 | 43 | 2 | GO:0140303 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 6.02e-03 | 172 | 43 | 3 | GO:0044325 | |
| GeneOntologyMolecularFunction | cholesterol binding | 6.94e-03 | 58 | 43 | 2 | GO:0015485 | |
| GeneOntologyMolecularFunction | proton transmembrane transporter activity | 7.69e-03 | 188 | 43 | 3 | GO:0015078 | |
| GeneOntologyMolecularFunction | sterol binding | 1.02e-02 | 71 | 43 | 2 | GO:0032934 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 1.11e-02 | 74 | 43 | 2 | GO:0005548 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 1.32e-02 | 81 | 43 | 2 | GO:0015370 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.33e-02 | 230 | 43 | 3 | GO:0005516 | |
| GeneOntologyMolecularFunction | syntaxin binding | 1.51e-02 | 87 | 43 | 2 | GO:0019905 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | CACNA1A CACNA1C CACNA1D CACNA1G SLC30A5 SLC12A1 SLC12A2 SLC24A4 MS4A1 | 1.24e-11 | 142 | 43 | 9 | GO:0099587 |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | CACNA1A CACNA1C CACNA1D CACNA1G SLC30A5 SLC12A1 SLC12A2 SLC24A4 MS4A1 | 1.24e-11 | 142 | 43 | 9 | GO:0098659 |
| GeneOntologyBiologicalProcess | metal ion transport | SCN10A CACNA1A CACNA1C CACNA1D PKD2L1 CACNA1G CACNG5 SLC30A5 ABCC2 SLC11A1 SLC12A1 SLC12A2 PKD2L2 SLC24A4 MS4A1 SLC22A5 | 6.38e-11 | 1000 | 43 | 16 | GO:0030001 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ANO4 SCN10A CACNA1A CACNA1C CACNA1D PKD2L1 CACNA1G CACNG5 SLC30A5 ABCC2 SLC11A1 SLC12A1 SLC12A2 PKD2L2 SLC24A4 MS4A1 | 8.19e-11 | 1017 | 43 | 16 | GO:0098660 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SCN10A CACNA1A CACNA1C CACNA1D PKD2L1 CACNA1G CACNG5 SLC30A5 ABCC2 SLC11A1 SLC12A1 SLC12A2 PKD2L2 SLC24A4 MS4A1 | 2.38e-10 | 922 | 43 | 15 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ANO4 SCN10A CACNA1A CACNA1C CACNA1D PKD2L1 CACNA1G CACNG5 SLC30A5 ABCC2 SLC11A1 SLC12A1 SLC12A2 PKD2L2 SLC24A4 MS4A1 | 3.18e-10 | 1115 | 43 | 16 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SCN10A CACNA1A CACNA1C CACNA1D PKD2L1 CACNA1G CACNG5 SLC30A5 ABCC2 SLC11A1 SLC12A1 SLC12A2 PKD2L2 SLC24A4 MS4A1 | 3.20e-10 | 942 | 43 | 15 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SCN10A CACNA1A CACNA1C CACNA1D PKD2L1 CACNA1G CACNG5 SLC30A5 ABCC2 SLC11A1 SLC12A1 SLC12A2 PKD2L2 SLC24A4 MS4A1 SLC22A5 | 5.46e-10 | 1157 | 43 | 16 | GO:0006812 |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 6.56e-10 | 48 | 43 | 6 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 6.56e-10 | 48 | 43 | 6 | GO:1902656 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ANO4 SCN10A CACNA1A CACNA1C CACNA1D PKD2L1 CACNA1G CACNG5 SLC30A5 ABCC2 SLC11A1 SLC12A1 SLC12A2 PKD2L2 SLC24A4 MS4A1 SLC22A5 | 7.27e-10 | 1374 | 43 | 17 | GO:0006811 |
| GeneOntologyBiologicalProcess | import across plasma membrane | CACNA1A CACNA1C CACNA1D CACNA1G SLC30A5 SLC12A1 SLC12A2 SLC24A4 MS4A1 | 9.25e-10 | 230 | 43 | 9 | GO:0098739 |
| GeneOntologyBiologicalProcess | detection of stimulus | SCN10A PKD2L1 TAS2R42 OR5H14 OR4C13 OR52K1 OR5AC2 SLC12A2 PKD2L2 OR52K2 SLC24A4 NLRC4 OR5H6 | 1.48e-09 | 722 | 43 | 13 | GO:0051606 |
| GeneOntologyBiologicalProcess | sensory perception | SCN10A CACNA1D PKD2L1 TAS2R42 OR5H14 SLC45A2 OR4C13 OR52K1 OR5AC2 SLC12A2 OR52K2 SLC24A4 CLRN3 OR5H6 | 1.83e-08 | 1072 | 43 | 14 | GO:0007600 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | SCN10A PKD2L1 TAS2R42 OR5H14 OR4C13 OR52K1 OR5AC2 SLC12A2 OR52K2 SLC24A4 OR5H6 | 2.08e-08 | 582 | 43 | 11 | GO:0050906 |
| GeneOntologyBiologicalProcess | calcium ion import | 5.21e-08 | 98 | 43 | 6 | GO:0070509 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | CACNA1A CACNA1C CACNA1D PKD2L1 CACNA1G CACNG5 PKD2L2 SLC24A4 MS4A1 | 9.40e-08 | 392 | 43 | 9 | GO:0070588 |
| GeneOntologyBiologicalProcess | chloride ion homeostasis | 2.01e-07 | 25 | 43 | 4 | GO:0055064 | |
| GeneOntologyBiologicalProcess | monoatomic anion homeostasis | 3.23e-07 | 28 | 43 | 4 | GO:0055081 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | PKD2L1 TAS2R42 OR5H14 OR4C13 OR52K1 OR5AC2 OR52K2 SLC24A4 OR5H6 | 5.65e-07 | 485 | 43 | 9 | GO:0050907 |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in cardiac conduction | 7.25e-07 | 34 | 43 | 4 | GO:0086019 | |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNA1A CACNA1C CACNA1D PKD2L1 CACNA1G CACNG5 PKD2L2 SLC24A4 MS4A1 | 8.45e-07 | 509 | 43 | 9 | GO:0006816 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 9.19e-07 | 36 | 43 | 4 | GO:0086010 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | PKD2L1 TAS2R42 OR5H14 OR4C13 OR52K1 OR5AC2 OR52K2 SLC24A4 OR5H6 | 1.08e-06 | 524 | 43 | 9 | GO:0009593 |
| GeneOntologyBiologicalProcess | import into cell | CACNA1A CACNA1C CACNA1D CACNA1G ABCA1 CACNG5 SLC30A5 SLC11A1 SLC12A1 SLC12A2 SLC24A4 MS4A1 | 1.28e-06 | 1074 | 43 | 12 | GO:0098657 |
| GeneOntologyBiologicalProcess | sodium ion transport | 1.48e-06 | 275 | 43 | 7 | GO:0006814 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | PKD2L1 TAS2R42 OR5H14 OR4C13 OR52K1 OR5AC2 OR52K2 SLC24A4 OR5H6 | 1.53e-06 | 547 | 43 | 9 | GO:0007606 |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell signaling | 1.83e-06 | 12 | 43 | 3 | GO:0086027 | |
| GeneOntologyBiologicalProcess | AV node cell action potential | 1.83e-06 | 12 | 43 | 3 | GO:0086016 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | ADGRB3 CACNA1D TAS2R42 OR5H14 OR4C13 OR52K1 ADGRF4 ABCA1 OR5AC2 OR52K2 SLC24A4 ADGRL3 OR5H6 | 3.16e-06 | 1395 | 43 | 13 | GO:0007186 |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell communication | 3.77e-06 | 15 | 43 | 3 | GO:0086067 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 4.37e-06 | 208 | 43 | 6 | GO:0035725 | |
| GeneOntologyBiologicalProcess | intracellular chloride ion homeostasis | 4.64e-06 | 16 | 43 | 3 | GO:0030644 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 5.15e-06 | 121 | 43 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 5.57e-06 | 217 | 43 | 6 | GO:0097553 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic anion homeostasis | 5.62e-06 | 17 | 43 | 3 | GO:0030002 | |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 6.86e-06 | 59 | 43 | 4 | GO:0086065 | |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization | 7.84e-06 | 61 | 43 | 4 | GO:0003254 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 8.36e-06 | 62 | 43 | 4 | GO:0086002 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | CACNA1A CACNA1C SLC45A2 SLC30A5 ABCC2 SLC11A1 SLC12A1 SLC12A2 SLC24A4 | 1.38e-05 | 717 | 43 | 9 | GO:0050801 |
| GeneOntologyBiologicalProcess | membrane depolarization during cardiac muscle cell action potential | 1.45e-05 | 23 | 43 | 3 | GO:0086012 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 1.79e-05 | 75 | 43 | 4 | GO:0050982 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | CACNA1A CACNA1C CACNA1D SLC45A2 SLC30A5 ABCC2 SLC11A1 SLC12A1 SLC12A2 SLC24A4 | 2.59e-05 | 981 | 43 | 10 | GO:0019725 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 2.83e-05 | 432 | 43 | 7 | GO:0050911 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 2.91e-05 | 173 | 43 | 5 | GO:0009581 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 3.08e-05 | 175 | 43 | 5 | GO:0009582 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 3.21e-05 | 87 | 43 | 4 | GO:0086001 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | CACNA1A CACNA1C CACNA1D SLC45A2 ABCA1 SLC30A5 ABCC2 SLC11A1 SLC12A1 SLC12A2 SLC24A4 | 3.66e-05 | 1249 | 43 | 11 | GO:0048878 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | CACNA1A CACNA1C SLC45A2 SLC30A5 ABCC2 SLC11A1 SLC12A2 SLC24A4 | 3.73e-05 | 622 | 43 | 8 | GO:0006873 |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | CACNA1A CACNA1C SLC30A5 ABCC2 SLC11A1 SLC12A1 SLC12A2 SLC24A4 | 3.73e-05 | 622 | 43 | 8 | GO:0098771 |
| GeneOntologyBiologicalProcess | export across plasma membrane | 3.84e-05 | 91 | 43 | 4 | GO:0140115 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 4.18e-05 | 93 | 43 | 4 | GO:0086003 | |
| GeneOntologyBiologicalProcess | membrane depolarization during SA node cell action potential | 4.23e-05 | 5 | 43 | 2 | GO:0086046 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 4.23e-05 | 5 | 43 | 2 | GO:1904879 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | 4.52e-05 | 465 | 43 | 7 | GO:0007608 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 5.55e-05 | 100 | 43 | 4 | GO:0061337 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | CACNA1A CACNA1C CACNA1D SLC45A2 SLC30A5 ABCC2 SLC11A1 SLC12A2 SLC24A4 | 6.06e-05 | 866 | 43 | 9 | GO:0055082 |
| GeneOntologyBiologicalProcess | membrane depolarization during AV node cell action potential | 6.33e-05 | 6 | 43 | 2 | GO:0086045 | |
| GeneOntologyBiologicalProcess | regulation of heart rate by cardiac conduction | 8.51e-05 | 41 | 43 | 3 | GO:0086091 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 8.63e-05 | 112 | 43 | 4 | GO:0019226 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | CACNA1A CACNA1C SLC45A2 SLC30A5 SLC11A1 SLC12A1 SLC12A2 SLC24A4 | 9.00e-05 | 705 | 43 | 8 | GO:0055080 |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | 1.17e-04 | 232 | 43 | 5 | GO:0071805 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.40e-04 | 127 | 43 | 4 | GO:0070252 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 1.49e-04 | 129 | 43 | 4 | GO:0002027 | |
| GeneOntologyBiologicalProcess | regulation of atrial cardiac muscle cell membrane depolarization | 1.89e-04 | 10 | 43 | 2 | GO:0060371 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell signaling | 1.89e-04 | 10 | 43 | 2 | GO:0086018 | |
| GeneOntologyBiologicalProcess | SA node cell action potential | 1.89e-04 | 10 | 43 | 2 | GO:0086015 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell communication | 2.31e-04 | 11 | 43 | 2 | GO:0086070 | |
| GeneOntologyBiologicalProcess | potassium ion transport | 2.46e-04 | 272 | 43 | 5 | GO:0006813 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | 2.47e-04 | 611 | 43 | 7 | GO:0030003 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.87e-04 | 153 | 43 | 4 | GO:0030048 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 2.87e-04 | 153 | 43 | 4 | GO:0098656 | |
| GeneOntologyBiologicalProcess | locomotory behavior | 3.00e-04 | 284 | 43 | 5 | GO:0007626 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 3.10e-04 | 286 | 43 | 5 | GO:0007188 | |
| GeneOntologyBiologicalProcess | high-density lipoprotein particle assembly | 3.26e-04 | 13 | 43 | 2 | GO:0034380 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 4.00e-04 | 167 | 43 | 4 | GO:0060048 | |
| GeneOntologyBiologicalProcess | behavior | 4.44e-04 | 891 | 43 | 8 | GO:0007610 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane depolarization | 5.00e-04 | 16 | 43 | 2 | GO:1904181 | |
| GeneOntologyBiologicalProcess | export from cell | CACNA1A CACNA1C CACNA1D CACNA1G ABCA1 ABCC2 SLC12A2 SLC24A4 SLC22A5 | 5.19e-04 | 1153 | 43 | 9 | GO:0140352 |
| GeneOntologyBiologicalProcess | inorganic anion transport | 5.31e-04 | 180 | 43 | 4 | GO:0015698 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 5.65e-04 | 183 | 43 | 4 | GO:0006820 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 6.63e-04 | 191 | 43 | 4 | GO:0007189 | |
| GeneOntologyBiologicalProcess | calcium-ion regulated exocytosis | 6.66e-04 | 82 | 43 | 3 | GO:0017156 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 7.17e-04 | 344 | 43 | 5 | GO:0003018 | |
| GeneOntologyBiologicalProcess | circulatory system process | 7.35e-04 | 733 | 43 | 7 | GO:0003013 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 7.92e-04 | 87 | 43 | 3 | GO:0150104 | |
| GeneOntologyBiologicalProcess | action potential | 8.02e-04 | 201 | 43 | 4 | GO:0001508 | |
| GeneOntologyBiologicalProcess | vascular transport | 8.19e-04 | 88 | 43 | 3 | GO:0010232 | |
| GeneOntologyBiologicalProcess | cellular response to cholesterol | 8.69e-04 | 21 | 43 | 2 | GO:0071397 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 9.55e-04 | 22 | 43 | 2 | GO:1902514 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 1.00e-03 | 559 | 43 | 6 | GO:0042391 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport via high voltage-gated calcium channel | 1.04e-03 | 23 | 43 | 2 | GO:0061577 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.07e-03 | 217 | 43 | 4 | GO:0006941 | |
| GeneOntologyBiologicalProcess | protein lipidation | 1.22e-03 | 101 | 43 | 3 | GO:0006497 | |
| GeneOntologyBiologicalProcess | detoxification of inorganic compound | 1.24e-03 | 25 | 43 | 2 | GO:0061687 | |
| GeneOntologyBiologicalProcess | cellular response to sterol | 1.34e-03 | 26 | 43 | 2 | GO:0036315 | |
| GeneOntologyBiologicalProcess | lipoprotein biosynthetic process | 1.40e-03 | 106 | 43 | 3 | GO:0042158 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol efflux | 1.44e-03 | 27 | 43 | 2 | GO:0010875 | |
| GeneOntologyBiologicalProcess | xenobiotic detoxification by transmembrane export across the plasma membrane | 1.44e-03 | 27 | 43 | 2 | GO:1990961 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 1.50e-03 | 238 | 43 | 4 | GO:0050954 | |
| GeneOntologyCellularComponent | calcium channel complex | 3.92e-07 | 73 | 43 | 5 | GO:0034704 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 2.38e-06 | 46 | 43 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | cation channel complex | 8.15e-06 | 235 | 43 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.10e-05 | 378 | 43 | 7 | GO:0034702 | |
| GeneOntologyCellularComponent | apical plasma membrane | 5.56e-05 | 487 | 43 | 7 | GO:0016324 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 8.70e-05 | 523 | 43 | 7 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 1.19e-04 | 550 | 43 | 7 | GO:1990351 | |
| GeneOntologyCellularComponent | synaptic membrane | 1.71e-04 | 583 | 43 | 7 | GO:0097060 | |
| GeneOntologyCellularComponent | apical part of cell | 1.87e-04 | 592 | 43 | 7 | GO:0045177 | |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 2.69e-04 | 12 | 43 | 2 | GO:1990454 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 5.51e-04 | 17 | 43 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | canonical inflammasome complex | 6.19e-04 | 18 | 43 | 2 | GO:0061702 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 1.28e-03 | 817 | 43 | 7 | GO:0098978 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.40e-03 | 405 | 43 | 5 | GO:0045211 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.62e-03 | 29 | 43 | 2 | GO:0034706 | |
| GeneOntologyCellularComponent | cell projection membrane | 1.84e-03 | 431 | 43 | 5 | GO:0031253 | |
| GeneOntologyCellularComponent | presynaptic membrane | 2.48e-03 | 277 | 43 | 4 | GO:0042734 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 4.12e-03 | 157 | 43 | 3 | GO:0098839 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 5.13e-03 | 785 | 43 | 6 | GO:0098797 | |
| GeneOntologyCellularComponent | cell surface | 7.07e-03 | 1111 | 43 | 7 | GO:0009986 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 8.15e-03 | 201 | 43 | 3 | GO:0099634 | |
| MousePheno | sinus bradycardia | 4.29e-06 | 14 | 33 | 3 | MP:0010637 | |
| Domain | VDCCAlpha1 | 5.06e-09 | 10 | 43 | 4 | IPR002077 | |
| Domain | Channel_four-helix_dom | 1.95e-07 | 57 | 43 | 5 | IPR027359 | |
| Domain | - | 1.95e-07 | 57 | 43 | 5 | 1.20.120.350 | |
| Domain | GPHH_dom | 3.95e-07 | 7 | 43 | 3 | IPR031649 | |
| Domain | VDCC_a1su_IQ | 3.95e-07 | 7 | 43 | 3 | IPR014873 | |
| Domain | Ca_chan_IQ | 3.95e-07 | 7 | 43 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 3.95e-07 | 7 | 43 | 3 | PF08763 | |
| Domain | GPHH | 3.95e-07 | 7 | 43 | 3 | PF16905 | |
| Domain | Na/K/Cl_cotranspt | 5.18e-06 | 2 | 43 | 2 | IPR002443 | |
| Domain | Ion_trans_dom | 6.20e-06 | 114 | 43 | 5 | IPR005821 | |
| Domain | Ion_trans | 6.20e-06 | 114 | 43 | 5 | PF00520 | |
| Domain | CAC1F_C | 1.55e-05 | 3 | 43 | 2 | PF16885 | |
| Domain | AA_permease_N | 1.55e-05 | 3 | 43 | 2 | IPR013612 | |
| Domain | AA_permease_N | 1.55e-05 | 3 | 43 | 2 | PF08403 | |
| Domain | CAC1F_C | 1.55e-05 | 3 | 43 | 2 | IPR031688 | |
| Domain | VDCC_L_a1su | 3.10e-05 | 4 | 43 | 2 | IPR005446 | |
| Domain | PC1 | 3.10e-05 | 4 | 43 | 2 | IPR000434 | |
| Domain | PKD_2 | 5.15e-05 | 5 | 43 | 2 | IPR003915 | |
| Domain | GPS | 7.07e-05 | 35 | 43 | 3 | PF01825 | |
| Domain | GPS | 7.70e-05 | 36 | 43 | 3 | PS50221 | |
| Domain | GPS | 8.36e-05 | 37 | 43 | 3 | IPR000203 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 1.06e-04 | 40 | 43 | 3 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 1.06e-04 | 40 | 43 | 3 | PS50227 | |
| Domain | GPCR_2_extracellular_dom | 1.06e-04 | 40 | 43 | 3 | IPR001879 | |
| Domain | SLC12A_fam | 1.08e-04 | 7 | 43 | 2 | IPR004842 | |
| Domain | SLC12 | 1.44e-04 | 8 | 43 | 2 | PF03522 | |
| Domain | SLC12_C | 1.44e-04 | 8 | 43 | 2 | IPR018491 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 2.07e-04 | 50 | 43 | 3 | PS00650 | |
| Domain | 7tm_2 | 2.07e-04 | 50 | 43 | 3 | PF00002 | |
| Domain | Olfact_rcpt | 2.64e-04 | 393 | 43 | 6 | IPR000725 | |
| Domain | GAIN_dom_N | 2.81e-04 | 11 | 43 | 2 | IPR032471 | |
| Domain | GAIN | 2.81e-04 | 11 | 43 | 2 | PF16489 | |
| Domain | PKD1_2_channel | 2.81e-04 | 11 | 43 | 2 | IPR013122 | |
| Domain | PKD_channel | 2.81e-04 | 11 | 43 | 2 | PF08016 | |
| Domain | GPCR_2-like | 3.55e-04 | 60 | 43 | 3 | IPR017981 | |
| Domain | GPCR_2_secretin-like | 3.55e-04 | 60 | 43 | 3 | IPR000832 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 3.73e-04 | 61 | 43 | 3 | PS50261 | |
| Domain | GPCR_Rhodpsn_7TM | 7.75e-04 | 670 | 43 | 7 | IPR017452 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 9.29e-04 | 691 | 43 | 7 | PS50262 | |
| Domain | GPCR_Rhodpsn | 9.37e-04 | 692 | 43 | 7 | IPR000276 | |
| Domain | AA-permease/SLC12A_dom | 1.16e-03 | 22 | 43 | 2 | IPR004841 | |
| Domain | AA_permease | 1.16e-03 | 22 | 43 | 2 | PF00324 | |
| Domain | NACHT | 1.27e-03 | 23 | 43 | 2 | PS50837 | |
| Domain | NACHT_NTPase | 1.27e-03 | 23 | 43 | 2 | IPR007111 | |
| Domain | HormR | 1.50e-03 | 25 | 43 | 2 | SM00008 | |
| Domain | HRM | 1.88e-03 | 28 | 43 | 2 | PF02793 | |
| Domain | GPS | 2.77e-03 | 34 | 43 | 2 | SM00303 | |
| Domain | GPCR_2_secretin-like_CS | 2.77e-03 | 34 | 43 | 2 | IPR017983 | |
| Domain | PMP22_Claudin | 3.82e-03 | 40 | 43 | 2 | PF00822 | |
| Domain | ABC_transporter_CS | 4.20e-03 | 42 | 43 | 2 | IPR017871 | |
| Domain | 7tm_1 | 4.31e-03 | 677 | 43 | 6 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 4.57e-03 | 685 | 43 | 6 | PS00237 | |
| Domain | PMP22/EMP/MP20/Claudin | 4.81e-03 | 45 | 43 | 2 | IPR004031 | |
| Domain | ABC_TRANSPORTER_2 | 5.46e-03 | 48 | 43 | 2 | PS50893 | |
| Domain | ABC_tran | 5.46e-03 | 48 | 43 | 2 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 5.69e-03 | 49 | 43 | 2 | PS00211 | |
| Domain | ABC_transporter-like | 5.91e-03 | 50 | 43 | 2 | IPR003439 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 4.81e-09 | 25 | 37 | 5 | M47948 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ANO4 MBTPS1 ABCA1 LMF2 SLC30A5 ABCC2 SLC11A1 SLC12A1 SLC12A2 SLC24A4 ZDHHC8 SLC22A5 | 2.08e-07 | 736 | 37 | 12 | M27287 |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 3.43e-07 | 23 | 37 | 4 | M47666 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ANO4 ABCA1 LMF2 SLC30A5 ABCC2 SLC11A1 SLC12A1 SLC12A2 SLC24A4 ZDHHC8 SLC22A5 | 8.34e-07 | 681 | 37 | 11 | MM14985 |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 6.61e-06 | 47 | 37 | 4 | M19708 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 3.26e-05 | 238 | 37 | 6 | MM15076 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 4.20e-05 | 249 | 37 | 6 | M5988 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE | 4.27e-05 | 75 | 37 | 4 | M27032 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 9.28e-05 | 177 | 37 | 5 | M27476 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 9.99e-05 | 6 | 37 | 2 | M47762 | |
| Pathway | REACTOME_HDL_ASSEMBLY | 1.40e-04 | 7 | 37 | 2 | MM15560 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 1.40e-04 | 7 | 37 | 2 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 1.40e-04 | 7 | 37 | 2 | MM15081 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.78e-04 | 42 | 37 | 3 | M7169 | |
| Pathway | REACTOME_HDL_ASSEMBLY | 1.86e-04 | 8 | 37 | 2 | M27840 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 3.63e-04 | 11 | 37 | 2 | M47958 | |
| Pathway | WP_MAPK_SIGNALING | 4.29e-04 | 246 | 37 | 5 | M39597 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 5.39e-04 | 61 | 37 | 3 | MM15071 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE | 5.66e-04 | 62 | 37 | 3 | MM14686 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 5.93e-04 | 63 | 37 | 3 | M11187 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 5.98e-04 | 14 | 37 | 2 | M47692 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 6.23e-04 | 267 | 37 | 5 | M10792 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 6.90e-04 | 417 | 37 | 6 | M4072 | |
| Pathway | WP_GPCRS_ODORANT | 7.35e-04 | 157 | 37 | 4 | MM15872 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 8.76e-04 | 72 | 37 | 3 | MM14631 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY | 8.89e-04 | 17 | 37 | 2 | MM15561 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 9.49e-04 | 74 | 37 | 3 | M39462 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 9.49e-04 | 74 | 37 | 3 | M16376 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 1.03e-03 | 76 | 37 | 3 | MM15072 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.11e-03 | 78 | 37 | 3 | M1921 | |
| Pathway | REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES | 1.11e-03 | 19 | 37 | 2 | M27839 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY | 1.11e-03 | 19 | 37 | 2 | M27841 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 1.15e-03 | 79 | 37 | 3 | M17673 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 1.16e-03 | 636 | 37 | 7 | M41834 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.17e-03 | 178 | 37 | 4 | M2890 | |
| Pathway | REACTOME_METAL_ION_SLC_TRANSPORTERS | 1.24e-03 | 20 | 37 | 2 | MM15077 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 1.32e-03 | 83 | 37 | 3 | M8728 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING | 1.36e-03 | 21 | 37 | 2 | M47950 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 1.37e-03 | 84 | 37 | 3 | M27334 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 1.67e-03 | 90 | 37 | 3 | M835 | |
| Pathway | REACTOME_METAL_ION_SLC_TRANSPORTERS | 1.78e-03 | 24 | 37 | 2 | M18795 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 2.20e-03 | 99 | 37 | 3 | M27474 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 2.43e-03 | 28 | 37 | 2 | M10679 | |
| Pathway | WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY | 2.78e-03 | 30 | 37 | 2 | MM15866 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 2.81e-03 | 108 | 37 | 3 | M17034 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.81e-03 | 108 | 37 | 3 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.89e-03 | 109 | 37 | 3 | MM15074 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 3.16e-03 | 32 | 37 | 2 | M27455 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 3.29e-03 | 389 | 37 | 5 | M14091 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 3.36e-03 | 33 | 37 | 2 | MM1448 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 3.57e-03 | 34 | 37 | 2 | M16393 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_REMODELING | 3.57e-03 | 34 | 37 | 2 | M27842 | |
| Pathway | WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY | 3.78e-03 | 35 | 37 | 2 | M39488 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 5.92e-03 | 44 | 37 | 2 | M11911 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 6.66e-03 | 147 | 37 | 3 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 7.17e-03 | 151 | 37 | 3 | M39329 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 8.18e-03 | 52 | 37 | 2 | M5785 | |
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 23338940 | ||
| Pubmed | Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature. | 7.04e-09 | 4 | 43 | 3 | 21788606 | |
| Pubmed | 1.76e-08 | 5 | 43 | 3 | 11296258 | ||
| Pubmed | 1.76e-08 | 5 | 43 | 3 | 15451373 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.97e-08 | 139 | 43 | 6 | 16985003 | |
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 12900400 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.45e-07 | 38 | 43 | 4 | 30786075 | |
| Pubmed | 1.47e-07 | 9 | 43 | 3 | 16382099 | ||
| Pubmed | 7.93e-07 | 15 | 43 | 3 | 20188150 | ||
| Pubmed | 7.93e-07 | 15 | 43 | 3 | 24453333 | ||
| Pubmed | Calcium handling precedes cardiac differentiation to initiate the first heartbeat. | 1.18e-06 | 17 | 43 | 3 | 27725084 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 24849370 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 20014384 | ||
| Pubmed | A Selectivity Filter Gate Controls Voltage-Gated Calcium Channel Calcium-Dependent Inactivation. | 1.49e-06 | 2 | 43 | 2 | 30733149 | |
| Pubmed | Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3. | 1.49e-06 | 2 | 43 | 2 | 26049024 | |
| Pubmed | L-type calcium channels contribute to the tottering mouse dystonic episodes. | 1.49e-06 | 2 | 43 | 2 | 9882694 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 9672238 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 17015854 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 11959145 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 30001160 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 19225208 | ||
| Pubmed | Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. | 1.49e-06 | 2 | 43 | 2 | 16706838 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 23761887 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 14981074 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 21352396 | ||
| Pubmed | CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. | 1.49e-06 | 2 | 43 | 2 | 25292336 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 20547676 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 17526649 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 12606379 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 16814616 | ||
| Pubmed | Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. | 1.49e-06 | 2 | 43 | 2 | 24941892 | |
| Pubmed | Palmitoylation of ATP-binding cassette transporter A1 is essential for its trafficking and function. | 1.49e-06 | 2 | 43 | 2 | 19556522 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 21054386 | ||
| Pubmed | Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells. | 1.49e-06 | 2 | 43 | 2 | 17409250 | |
| Pubmed | Neuronal L-type calcium channels open quickly and are inhibited slowly. | 1.49e-06 | 2 | 43 | 2 | 16267232 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 24848473 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 33144668 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 22826131 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 24996399 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 7929272 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 24470632 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 27418245 | ||
| Pubmed | Increased Slc12a1 expression in β-cells and improved glucose disposal in Slc12a2 heterozygous mice. | 1.49e-06 | 2 | 43 | 2 | 26400961 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 24760982 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 8640224 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 24086669 | ||
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 2.84e-06 | 79 | 43 | 4 | 12679517 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 19351867 | ||
| Pubmed | Truncation of murine CaV1.2 at Asp-1904 results in heart failure after birth. | 4.48e-06 | 3 | 43 | 2 | 21832054 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 17289261 | ||
| Pubmed | Polycystin-2 expression and function in adult mouse lacrimal acinar cells. | 4.48e-06 | 3 | 43 | 2 | 21508103 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 24966091 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 21406960 | ||
| Pubmed | Potent inhibition of L-type Ca2+ currents by a Rad variant associated with congestive heart failure. | 4.48e-06 | 3 | 43 | 2 | 23973784 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 26216687 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 31919478 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 26831068 | ||
| Pubmed | Genes homologous to the autosomal dominant polycystic kidney disease genes (PKD1 and PKD2). | 4.48e-06 | 3 | 43 | 2 | 10602361 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 17767505 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 37739992 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 31302118 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 8663127 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 23045342 | ||
| Pubmed | Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation. | 4.48e-06 | 3 | 43 | 2 | 26507659 | |
| Pubmed | Loss of calcium channels in the cerebellum of the ataxic and epileptic stargazer mutant mouse. | 4.48e-06 | 3 | 43 | 2 | 19422811 | |
| Pubmed | Decreased cardiac L-type Ca²⁺ channel activity induces hypertrophy and heart failure in mice. | 4.48e-06 | 3 | 43 | 2 | 22133878 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 32555258 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 29581247 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 2173707 | ||
| Pubmed | Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons. | 4.48e-06 | 3 | 43 | 2 | 24934288 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 32154672 | ||
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 6.29e-06 | 29 | 43 | 3 | 15203201 | |
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 31800012 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 21972418 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 15728831 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 20819979 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 20937870 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 22989884 | ||
| Pubmed | G protein-gated inhibitory module of N-type (ca(v)2.2) ca2+ channels. | 8.94e-06 | 4 | 43 | 2 | 15953418 | |
| Pubmed | Molecular coupling of a Ca2+-activated K+ channel to L-type Ca2+ channels via alpha-actinin2. | 8.94e-06 | 4 | 43 | 2 | 17110593 | |
| Pubmed | Role of the alpha1G T-type calcium channel in spontaneous absence seizures in mutant mice. | 8.94e-06 | 4 | 43 | 2 | 15175395 | |
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 9.36e-06 | 33 | 43 | 3 | 25713288 | |
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 11698076 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 31663850 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 12060068 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 16787652 | ||
| Pubmed | Role of the caspase-1 inflammasome in Salmonella typhimurium pathogenesis. | 1.49e-05 | 5 | 43 | 2 | 16717117 | |
| Pubmed | Voltage-gated calcium channels in developing GnRH-1 neuronal system in the mouse. | 2.23e-05 | 6 | 43 | 2 | 16029198 | |
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 21224388 | ||
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 23734214 | ||
| Pubmed | Novel gene function revealed by mouse mutagenesis screens for models of age-related disease. | 2.25e-05 | 44 | 43 | 3 | 27534441 | |
| Pubmed | 2.41e-05 | 45 | 43 | 3 | 25979088 | ||
| Pubmed | 2.99e-05 | 143 | 43 | 4 | 20424473 | ||
| Pubmed | 3.12e-05 | 7 | 43 | 2 | 21057379 | ||
| Pubmed | 4.16e-05 | 8 | 43 | 2 | 28330839 | ||
| Pubmed | Similar effects of all WNK3 variants on SLC12 cotransporters. | 4.16e-05 | 8 | 43 | 2 | 21613606 | |
| Pubmed | 4.16e-05 | 8 | 43 | 2 | 21737792 | ||
| Pubmed | 4.16e-05 | 8 | 43 | 2 | 19710684 | ||
| Pubmed | 4.16e-05 | 8 | 43 | 2 | 18483556 | ||
| Pubmed | Intracellular calcium plays an essential role in cardiac development. | 4.16e-05 | 8 | 43 | 2 | 12761855 | |
| Interaction | SCN11A interactions | 1.61e-08 | 15 | 39 | 4 | int:SCN11A | |
| Interaction | CACNA1D interactions | 1.24e-07 | 24 | 39 | 4 | int:CACNA1D | |
| Interaction | SCN1A interactions | 2.75e-07 | 29 | 39 | 4 | int:SCN1A | |
| Interaction | SCN10A interactions | 1.09e-06 | 11 | 39 | 3 | int:SCN10A | |
| Interaction | SCN5A interactions | 2.01e-06 | 47 | 39 | 4 | int:SCN5A | |
| Interaction | SCN9A interactions | 8.70e-06 | 21 | 39 | 3 | int:SCN9A | |
| Interaction | CACNB2 interactions | 1.16e-05 | 23 | 39 | 3 | int:CACNB2 | |
| Interaction | CACNA1B interactions | 4.97e-05 | 37 | 39 | 3 | int:CACNA1B | |
| Interaction | CACNA1A interactions | 9.21e-05 | 123 | 39 | 4 | int:CACNA1A | |
| Interaction | CACNA1C interactions | 2.23e-04 | 61 | 39 | 3 | int:CACNA1C | |
| Interaction | PDZK1 interactions | 2.82e-04 | 66 | 39 | 3 | int:PDZK1 | |
| Interaction | NALCN interactions | 3.27e-04 | 14 | 39 | 2 | int:NALCN | |
| Interaction | CABP1 interactions | 3.77e-04 | 15 | 39 | 2 | int:CABP1 | |
| Cytoband | 3q12.1 | 1.01e-06 | 21 | 43 | 3 | 3q12.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q11 | 1.84e-05 | 54 | 43 | 3 | chr3q11 | |
| Cytoband | 5q23.3 | 7.74e-05 | 14 | 43 | 2 | 5q23.3 | |
| Cytoband | 10q24 | 5.00e-04 | 35 | 43 | 2 | 10q24 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.50e-09 | 26 | 36 | 5 | 253 | |
| GeneFamily | Solute carriers | 1.09e-05 | 395 | 36 | 7 | 752 | |
| GeneFamily | NLR family | 1.12e-03 | 25 | 36 | 2 | 666 | |
| GeneFamily | Transient receptor potential cation channels | 1.41e-03 | 28 | 36 | 2 | 249 | |
| GeneFamily | Olfactory receptors, family 5 | 1.42e-03 | 112 | 36 | 3 | 152 | |
| GeneFamily | Olfactory receptors, family 52 | 4.27e-03 | 49 | 36 | 2 | 165 | |
| Coexpression | GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_UP | 1.44e-05 | 199 | 41 | 5 | M5692 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 2.29e-07 | 139 | 43 | 5 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-06 | 189 | 43 | 5 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.22e-06 | 195 | 43 | 5 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.22e-06 | 195 | 43 | 5 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 157 | 43 | 4 | 0ad242320ada7bcb9e29548d3050bf4fd3a07115 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 157 | 43 | 4 | fe4c9556806203e57522d1986754ebe5a20aa2de | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-05 | 162 | 43 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.65e-05 | 179 | 43 | 4 | b07ebfd4157ae7436f275add78f2ac9ffc55f417 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 2.77e-05 | 181 | 43 | 4 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.77e-05 | 181 | 43 | 4 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.77e-05 | 181 | 43 | 4 | 79102845baee5af583eec24e9f91dfec46ab7de3 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 2.89e-05 | 183 | 43 | 4 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 3.01e-05 | 185 | 43 | 4 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.08e-05 | 186 | 43 | 4 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 3.41e-05 | 191 | 43 | 4 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.41e-05 | 191 | 43 | 4 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.48e-05 | 192 | 43 | 4 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.55e-05 | 193 | 43 | 4 | 50c2832de75b6469f649355c6b9a75e910d32db3 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.55e-05 | 193 | 43 | 4 | 222829c30ebe47f0ed1e035897e3cd4be10b2a11 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.63e-05 | 194 | 43 | 4 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 3.70e-05 | 195 | 43 | 4 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-TRAM-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.85e-05 | 197 | 43 | 4 | eecb693367510da20a6b1e9355e68785a1e3b85c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.93e-05 | 198 | 43 | 4 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-05 | 198 | 43 | 4 | d6812494874be0c14361ac2ac3e418b335bb8f55 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-04 | 114 | 43 | 3 | b350140b389f8762c77a37df473081e1127a8972 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.55e-04 | 128 | 43 | 3 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type | 2.61e-04 | 129 | 43 | 3 | 57b705106aec7bbfc587de1ccd4f2335fc44dd6f | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia-Acute_Myeloid_Leukemia-3|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 3.05e-04 | 136 | 43 | 3 | 4f5e0b6c7d6e3e922af4daa7c3eb56490455c1df | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 145 | 43 | 3 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | tumor_Lung-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 3.76e-04 | 146 | 43 | 3 | 8b2d104fdb0fdb09410450c6c651e1edb00cae44 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.76e-04 | 146 | 43 | 3 | 669001b772b6d6109a09727619ed5829122b48db | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D122|Adult / Lineage, Cell type, age group and donor | 3.91e-04 | 148 | 43 | 3 | 81a1e6fdd942a612bf523c59b8b4974f6ca1fdce | |
| ToppCell | Ciliated_cells-B-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 3.99e-04 | 149 | 43 | 3 | 6399c5a2f06d79f020dece252526f1c0c110d569 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.64e-04 | 157 | 43 | 3 | f6210be2362d833c6d869ff921188bfc85dda11d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.64e-04 | 157 | 43 | 3 | 43a6b423fd70479822a564ff4225a1e4951ae5ed | |
| ToppCell | IPF-Epithelial-Ionocyte|Epithelial / Disease state, Lineage and Cell class | 4.73e-04 | 158 | 43 | 3 | 67adf625a959444762d32268b3b7441f6f8b3b8c | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.91e-04 | 160 | 43 | 3 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 5.00e-04 | 161 | 43 | 3 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_4|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.00e-04 | 161 | 43 | 3 | 5cd483b73bcb3615ea56eb81c1c293e61b84b66d | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-04 | 162 | 43 | 3 | 71d7849108a1b59beff40e46000172c45a2f5439 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.09e-04 | 162 | 43 | 3 | d28b2ea1d2c8f3c6a107991573471b6d0c49c4ae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.09e-04 | 162 | 43 | 3 | eed223e61c8162a2fe004ab4e09de5e037be7553 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM2|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 5.09e-04 | 162 | 43 | 3 | e5fc80ab19d513af6a7e677a5e67bfebca2e963b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.09e-04 | 162 | 43 | 3 | 5bbd7130d4dad9035e73a439dda568195c136f31 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T7|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.09e-04 | 162 | 43 | 3 | c6ace47daf32495b25793d39b72382978349597d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.09e-04 | 162 | 43 | 3 | e35ddce830e20ebeac1a2c405293fc4a5323dd4a | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-04 | 163 | 43 | 3 | 04152557aae230e9587fcc16cbabf1247cc5b419 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-3|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 5.18e-04 | 163 | 43 | 3 | 0e8d3c98209fc98b86b841d69051cee9e276d837 | |
| ToppCell | Control-APC-like-Monocytes|Control / group, cell type (main and fine annotations) | 5.18e-04 | 163 | 43 | 3 | 4bc80a2c741d462724b6f3902377d48c57478932 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-04 | 163 | 43 | 3 | 0644eb8a66d4e944063125c423de66d2393388b1 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-04 | 164 | 43 | 3 | 758e85e2f5e7236b345e16c78344d5e0bf17d8dc | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-04 | 164 | 43 | 3 | 07d9252b267cb61c6050fbfa5b440aef1349f673 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.27e-04 | 164 | 43 | 3 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-04 | 164 | 43 | 3 | 7c016236f0cea38195c1373ebbd2c0b2b2ec81ad | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B-ABC_aged-B_memory|Lung / Manually curated celltypes from each tissue | 5.27e-04 | 164 | 43 | 3 | 7766900740f67dbbe3c4d90fbfdcc1665cee6515 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-04 | 165 | 43 | 3 | cd8de98af8a1a8a6c81d71fae807cc07f319f4c9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-04 | 165 | 43 | 3 | 4f83ac71efc57be3668d8db1e62bad05dc6a5e2b | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 5.37e-04 | 165 | 43 | 3 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-04 | 166 | 43 | 3 | f742d15b02a6f651bbd00f53e3d871f40d05a03d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-04 | 166 | 43 | 3 | e941df9a1091164edde3def8fc7d410186b2bd88 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-04 | 166 | 43 | 3 | 91eeb48680dd07ae4115afacdc0a8f6fa18885e5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-04 | 166 | 43 | 3 | aeda46bea5d8463c24a83b98b9ed92d962d733e5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-04 | 166 | 43 | 3 | 0f013bb5fdb72e88c2fc73d60cd01551a2db6341 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-04 | 167 | 43 | 3 | 7cb1b11e8e24a10115e46ffbb74889e672a7a026 | |
| ToppCell | droplet-Heart-nan-3m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-04 | 167 | 43 | 3 | 47447bcf184b1ad24ef17e135199fe7cd1d73c02 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-04 | 167 | 43 | 3 | bb53a478b5d821d6d82c15bc4ed075b67682457c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-04 | 167 | 43 | 3 | e228b8373ffd4436e6b944e26d0fadf3ac289b21 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-04 | 167 | 43 | 3 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | Ciliated_cells-A-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 5.56e-04 | 167 | 43 | 3 | edb722ee9b6ccd00fb038f702be8664020932659 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 5.66e-04 | 168 | 43 | 3 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.66e-04 | 168 | 43 | 3 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 5.66e-04 | 168 | 43 | 3 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-D_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.75e-04 | 169 | 43 | 3 | f982f2e0d341fa27229f443ebe5c0e4a9e63bda6 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-6|TCGA-Liver / Sample_Type by Project: Shred V9 | 5.75e-04 | 169 | 43 | 3 | e992530776cab922d0360b275fb9cb8bd0017b06 | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 5.75e-04 | 169 | 43 | 3 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-D_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.75e-04 | 169 | 43 | 3 | 818ab7a6fd1940a22d3bd99fe15f0af888af6b3e | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 5.85e-04 | 170 | 43 | 3 | d682178d11d67eb5a02d0c6b3967645e37bcc62a | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.85e-04 | 170 | 43 | 3 | 79420950d5e4b5da9f52d2a8a8ce096ae44a5edf | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-04 | 170 | 43 | 3 | b535baeb4dbd644051cf992babb61add9eaae4e3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-04 | 170 | 43 | 3 | 2477c9f29dbe27f172df699003971e828d6ab8c9 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.95e-04 | 171 | 43 | 3 | b520d4d5620cac08315e4cbb7e796c5e9e233060 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.06e-04 | 172 | 43 | 3 | f0e767a20d93e546ce278db67dbd779cc68af533 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.16e-04 | 173 | 43 | 3 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.16e-04 | 173 | 43 | 3 | a7cc63bb3ab41feb9e4072700d44dbbbc62c47c6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.16e-04 | 173 | 43 | 3 | e3e3a67a5a93ef4475224a256d45ae24526383cc | |
| ToppCell | facs-Trachea-nan-24m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.16e-04 | 173 | 43 | 3 | 27ae126c720f20d1fe116abbcd358e4cff8baf6b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.16e-04 | 173 | 43 | 3 | 0a0127bcb1d7b2b6125faef576dd843055095528 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-skeletal_muscle_satellite_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-04 | 174 | 43 | 3 | f230d23618a6487f2664efb2c677e0a4559e2bf4 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.26e-04 | 174 | 43 | 3 | f520b79d277e286c9bb5d091e6c94e7ec7e46699 | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.26e-04 | 174 | 43 | 3 | f1510b0f7771936adf29ae3572feab55db31832b | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.26e-04 | 174 | 43 | 3 | 5d5d2fc60afff47f997751e8e9ca1367a22d19ec | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.26e-04 | 174 | 43 | 3 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.37e-04 | 175 | 43 | 3 | 282f09bbdfa70d93b3f66591dcfb84c5ee0268c7 | |
| ToppCell | Bronchial_Biopsy-Immune-Luminal_Macrophages|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.37e-04 | 175 | 43 | 3 | 1cf99de391552d4f8dbe2ed5b01fc3b8adca61b6 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.37e-04 | 175 | 43 | 3 | d983e80eeb11f341c564ea684e2b0b585a90ae58 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.37e-04 | 175 | 43 | 3 | 53e6f1f8dd482dfa2539e068dacefbb6e08443bc | |
| ToppCell | pdx-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.47e-04 | 176 | 43 | 3 | 1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.58e-04 | 177 | 43 | 3 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.58e-04 | 177 | 43 | 3 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.58e-04 | 177 | 43 | 3 | e8bb4f8ecd5e283efec966b9fc2040a6152d5551 | |
| Drug | amiloride | CACNA1A CACNA1C CACNA1D PKD2L1 CACNG5 SLC12A1 SLC12A2 PKD2L2 SLC24A4 | 4.95e-09 | 315 | 42 | 9 | CID000016230 |
| Drug | lanthanum | 5.26e-09 | 136 | 42 | 7 | CID000023926 | |
| Drug | Verapamil | 1.79e-08 | 16 | 42 | 4 | DB00661 | |
| Drug | nitrendipine | 2.52e-08 | 98 | 42 | 6 | CID000004507 | |
| Drug | isradipine | 2.85e-08 | 100 | 42 | 6 | CID000003784 | |
| Drug | Cinildipine | 5.95e-08 | 56 | 42 | 5 | CID000002752 | |
| Drug | lamotrigine | 6.93e-08 | 116 | 42 | 6 | CID000003878 | |
| Drug | nilvadipine | 8.46e-08 | 60 | 42 | 5 | CID000004494 | |
| Drug | IAA-94 | 9.20e-08 | 61 | 42 | 5 | CID000003667 | |
| Drug | lercanidipine | 1.08e-07 | 63 | 42 | 5 | CID000065866 | |
| Drug | bepridil | 1.14e-07 | 126 | 42 | 6 | CID000002351 | |
| Drug | gallopamil | 1.48e-07 | 67 | 42 | 5 | CID000001234 | |
| Drug | AC1L2AC7 | 1.72e-07 | 69 | 42 | 5 | CID000068733 | |
| Drug | verapamil | SCN10A CACNA1A CACNA1C CACNA1D CACNA1G ABCA1 CACNG5 ABCC2 SLC22A5 | 2.18e-07 | 490 | 42 | 9 | CID000002520 |
| Drug | CAS 298-57-7 | 2.29e-07 | 73 | 42 | 5 | CID000002761 | |
| Drug | ethosuximide | 2.45e-07 | 74 | 42 | 5 | CID000003291 | |
| Drug | Dantrolene-13C3 | 2.61e-07 | 145 | 42 | 6 | CID000002951 | |
| Drug | nisoldipine | 3.19e-07 | 78 | 42 | 5 | CID000004499 | |
| Drug | procaine | 3.59e-07 | 153 | 42 | 6 | CID000004914 | |
| Drug | CNS 1145 | 3.94e-07 | 33 | 42 | 4 | CID000190902 | |
| Drug | IHC-64 | 3.94e-07 | 33 | 42 | 4 | CID000162753 | |
| Drug | Allethrin | 4.46e-07 | 34 | 42 | 4 | ctd:D000487 | |
| Drug | Cinnarizine | 4.87e-07 | 9 | 42 | 3 | DB00568 | |
| Drug | gabapentin | 6.43e-07 | 169 | 42 | 6 | CID000003446 | |
| Drug | manidipine | 8.56e-07 | 95 | 42 | 5 | CID000004008 | |
| Drug | Mibefradil | 9.53e-07 | 11 | 42 | 3 | DB01388 | |
| Drug | loperamide | 1.41e-06 | 105 | 42 | 5 | CID000003954 | |
| Drug | Pentamidine isethionate [140-64-7]; Up 200; 6.8uM; HL60; HT_HG-U133A | 1.62e-06 | 198 | 42 | 6 | 2473_UP | |
| Drug | gadolinium | 1.67e-06 | 199 | 42 | 6 | CID000023982 | |
| Drug | AC1L1JG6 | 2.09e-06 | 14 | 42 | 3 | CID000005026 | |
| Drug | KW-3049 | 2.17e-06 | 50 | 42 | 4 | CID000002324 | |
| Drug | phenytoin | 2.91e-06 | 219 | 42 | 6 | CID000001775 | |
| Drug | pimozide | 3.60e-06 | 127 | 42 | 5 | CID000016362 | |
| Drug | enzacamene | 3.88e-06 | 129 | 42 | 5 | ctd:C038939 | |
| Drug | octylmethoxycinnamate | 5.60e-06 | 139 | 42 | 5 | ctd:C118580 | |
| Drug | mibefradil | 5.86e-06 | 64 | 42 | 4 | CID000060662 | |
| Drug | isovalerate | 6.43e-06 | 143 | 42 | 5 | CID000010430 | |
| Drug | cobalt-60 | 6.60e-06 | 390 | 42 | 7 | CID000061492 | |
| Drug | AC1L1TJF | 6.63e-06 | 66 | 42 | 4 | CID000003377 | |
| Drug | nimodipine | 6.88e-06 | 145 | 42 | 5 | CID000004497 | |
| Drug | nicardipine | 6.88e-06 | 145 | 42 | 5 | CID000004473 | |
| Drug | Bay K 8644 | 8.11e-06 | 150 | 42 | 5 | CID000002303 | |
| Drug | Barium | 9.39e-06 | 72 | 42 | 4 | ctd:D001464 | |
| Drug | bromide;iodide | 9.95e-06 | 3 | 42 | 2 | CID009907214 | |
| Drug | butylparaben | 1.01e-05 | 157 | 42 | 5 | ctd:C038091 | |
| Drug | potassium | SCN10A CACNA1A CACNA1C CACNA1D CACNA1G CACNG5 SLC11A1 SLC12A1 SLC12A2 SLC24A4 | 1.12e-05 | 1008 | 42 | 10 | CID000000813 |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 1.36e-05 | 79 | 42 | 4 | CID005287890 | |
| Drug | felodipine | 1.45e-05 | 169 | 42 | 5 | CID000003333 | |
| Drug | riluzole | 1.67e-05 | 174 | 42 | 5 | CID000005070 | |
| Drug | NSC-686960 | 1.99e-05 | 4 | 42 | 2 | CID000192816 | |
| Drug | AC1L2PB2 | 1.99e-05 | 4 | 42 | 2 | CID000125849 | |
| Drug | NSC7524 | 2.07e-05 | 182 | 42 | 5 | CID000005657 | |
| Drug | halothane | 2.27e-05 | 314 | 42 | 6 | CID000003562 | |
| Drug | AC1NUZ8M | 2.48e-05 | 92 | 42 | 4 | CID000073211 | |
| Drug | NSC759576 | 2.61e-05 | 191 | 42 | 5 | CID000003075 | |
| Drug | dihydropyridine | 2.74e-05 | 193 | 42 | 5 | CID000104822 | |
| Drug | uranyl nitrate | 2.79e-05 | 32 | 42 | 3 | CID000024933 | |
| Drug | Gossypol [303-45-7]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 2.88e-05 | 195 | 42 | 5 | 6058_UP | |
| Drug | Flurandrenolide [1524-88-5]; Up 200; 9.2uM; PC3; HT_HG-U133A | 2.95e-05 | 196 | 42 | 5 | 7378_UP | |
| Drug | isotetrandrine | 3.06e-05 | 97 | 42 | 4 | CID000005422 | |
| Drug | Bergenin monohydrate [477-90-7]; Down 200; 11.6uM; HL60; HT_HG-U133A | 3.10e-05 | 198 | 42 | 5 | 2726_DN | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; HL60; HT_HG-U133A | 3.17e-05 | 199 | 42 | 5 | 2725_DN | |
| Drug | Ozagrel hydrochloride [78712-43-3]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 3.25e-05 | 200 | 42 | 5 | 3503_UP | |
| Drug | Piribedil hydrochloride [78213-63-5]; Up 200; 12uM; PC3; HT_HG-U133A | 3.25e-05 | 200 | 42 | 5 | 6333_UP | |
| Drug | Nilvadipine | 3.31e-05 | 5 | 42 | 2 | DB06712 | |
| Drug | Nisoldipine | 3.31e-05 | 5 | 42 | 2 | DB00401 | |
| Drug | Quinethazone | 3.31e-05 | 5 | 42 | 2 | DB01325 | |
| Drug | B 874-67 | 3.31e-05 | 5 | 42 | 2 | CID000195466 | |
| Drug | methyl beta-aminocrotonate | 3.31e-05 | 5 | 42 | 2 | CID000084253 | |
| Drug | Bumetanide | 3.31e-05 | 5 | 42 | 2 | DB00887 | |
| Drug | nemadipine-A | 3.31e-05 | 5 | 42 | 2 | CID002856102 | |
| Drug | pyraclofos | 4.34e-05 | 106 | 42 | 4 | CID000093460 | |
| Drug | sodium | SCN10A CACNA1C CACNA1D ABCC2 SLC11A1 SLC12A1 SLC12A2 SLC24A4 SLC22A5 | 4.52e-05 | 944 | 42 | 9 | CID000000923 |
| Drug | CPU-23 | 4.96e-05 | 6 | 42 | 2 | CID003036051 | |
| Drug | 3,4-dihydroquinazoline | 4.96e-05 | 6 | 42 | 2 | CID000583065 | |
| Drug | Potassium Chloride | 4.96e-05 | 6 | 42 | 2 | DB00761 | |
| Drug | Nifedipine | 5.38e-05 | 112 | 42 | 4 | ctd:D009543 | |
| Drug | AC1NBU2S | 6.38e-05 | 117 | 42 | 4 | CID004473765 | |
| Drug | valproate | 6.66e-05 | 381 | 42 | 6 | CID000003121 | |
| Drug | NiCl2 | 6.81e-05 | 119 | 42 | 4 | CID000024385 | |
| Drug | Amlodipine | 6.94e-05 | 7 | 42 | 2 | DB00381 | |
| Drug | Isradipine | 6.94e-05 | 7 | 42 | 2 | DB00270 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | 7.33e-05 | 568 | 42 | 7 | CID000000806 | |
| Drug | fluo-3 | 7.50e-05 | 122 | 42 | 4 | CID000104978 | |
| Drug | h PM | 7.85e-05 | 45 | 42 | 3 | CID005494424 | |
| Drug | aldosterone | 8.35e-05 | 397 | 42 | 6 | CID000005839 | |
| Drug | frovatriptan | 8.38e-05 | 46 | 42 | 3 | CID000077992 | |
| Drug | amlodipine | 8.50e-05 | 126 | 42 | 4 | CID000002162 | |
| Drug | Linuron | 9.04e-05 | 128 | 42 | 4 | ctd:D008044 | |
| Drug | myristoylcarnitine | 9.24e-05 | 8 | 42 | 2 | CID003413344 | |
| Drug | 1,5-benzothiazepin-4(5H)-one | 9.24e-05 | 8 | 42 | 2 | CID000358939 | |
| Drug | Nifedipine | 9.24e-05 | 8 | 42 | 2 | DB01115 | |
| Drug | Nitrendipine | 9.24e-05 | 8 | 42 | 2 | DB01054 | |
| Drug | Barium permanganate | 1.05e-04 | 133 | 42 | 4 | CID000024587 | |
| Drug | nifedipine | 1.06e-04 | 415 | 42 | 6 | CID000004485 | |
| Drug | azelnidipine | 1.14e-04 | 51 | 42 | 3 | CID000065948 | |
| Drug | Nimodipine | 1.19e-04 | 9 | 42 | 2 | DB00393 | |
| Drug | tetradotoxin | 1.26e-04 | 428 | 42 | 6 | CID000020382 | |
| Drug | prochloraz | 1.30e-04 | 268 | 42 | 5 | ctd:C045362 | |
| Drug | AC1L3TPS | 1.48e-04 | 10 | 42 | 2 | CID000121952 | |
| Disease | Shortened QT interval | 4.39e-07 | 11 | 42 | 3 | C0151879 | |
| Disease | Renal carnitine transport defect | 1.98e-06 | 2 | 42 | 2 | C0342788 | |
| Disease | epilepsy (implicated_via_orthology) | 3.49e-06 | 163 | 42 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | polycystic kidney disease 2 (implicated_via_orthology) | 5.93e-06 | 3 | 42 | 2 | DOID:0110859 (implicated_via_orthology) | |
| Disease | Timothy syndrome (implicated_via_orthology) | 1.18e-05 | 4 | 42 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | Auriculo-Ventricular Dissociation | 1.18e-05 | 4 | 42 | 2 | C0004331 | |
| Disease | Heart Block | 1.18e-05 | 4 | 42 | 2 | C0018794 | |
| Disease | pigmentation disease (is_implicated_in) | 1.08e-04 | 11 | 42 | 2 | DOID:10123 (is_implicated_in) | |
| Disease | hair colour measurement, hair morphology measurement | 1.29e-04 | 12 | 42 | 2 | EFO_0007821, EFO_0007822 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 1.53e-04 | 13 | 42 | 2 | EFO_0800474 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 1.78e-04 | 14 | 42 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | Sinus Node Dysfunction (disorder) | 2.05e-04 | 15 | 42 | 2 | C0428908 | |
| Disease | Brugada Syndrome (disorder) | 5.35e-04 | 24 | 42 | 2 | C1142166 | |
| Disease | Cardiac Arrhythmia | 5.81e-04 | 25 | 42 | 2 | C0003811 | |
| Disease | cardiovascular age measurement | 7.84e-04 | 29 | 42 | 2 | EFO_0803380 | |
| Disease | Crohn's disease (is_implicated_in) | 8.39e-04 | 30 | 42 | 2 | DOID:8778 (is_implicated_in) | |
| Disease | skin pigmentation measurement | 9.85e-04 | 137 | 42 | 3 | EFO_0007009 | |
| Disease | fatty liver disease (biomarker_via_orthology) | 1.02e-03 | 33 | 42 | 2 | DOID:9452 (biomarker_via_orthology) | |
| Disease | Spinocerebellar Ataxia Type 2 | 1.08e-03 | 34 | 42 | 2 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 1.08e-03 | 34 | 42 | 2 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 1.08e-03 | 34 | 42 | 2 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 1.08e-03 | 34 | 42 | 2 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 1.08e-03 | 34 | 42 | 2 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 1.08e-03 | 34 | 42 | 2 | C0087012 | |
| Disease | visual epilepsy (implicated_via_orthology) | 1.08e-03 | 34 | 42 | 2 | DOID:11832 (implicated_via_orthology) | |
| Disease | Spinocerebellar Ataxia Type 4 | 1.14e-03 | 35 | 42 | 2 | C0752122 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.21e-03 | 36 | 42 | 2 | DOID:11723 (implicated_via_orthology) | |
| Disease | resting heart rate | 1.25e-03 | 149 | 42 | 3 | EFO_0004351 | |
| Disease | skin microbiome measurement | 1.42e-03 | 39 | 42 | 2 | EFO_0801228 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FMFIFAVVAVQLFKG | 1386 | O00555 | |
| LFAVFDSLQGFVIVM | 1131 | O60242 | |
| RNLFAMAVEGVVFFL | 1851 | O95477 | |
| NAFQGFFILLFGTIM | 641 | Q8IZF3 | |
| FTIFNSLQGMFIFIF | 1086 | Q9HAR2 | |
| MAFSFFRVAAILQGV | 551 | Q6JQN1 | |
| LFDNGATVFFAVFMA | 421 | Q32M45 | |
| MILQFGFTTIFVAAF | 716 | Q32M45 | |
| VMLIFAFFQELVIAG | 196 | P11836 | |
| FSIMIEFNVFTFVNL | 601 | Q8NFF2 | |
| FLMVFIFAGSIQVFT | 196 | A6NHG9 | |
| VFVFQLFTMEKGNRF | 81 | P54849 | |
| AFMGVFENLKQLVFF | 956 | Q9NPP4 | |
| AFLGAMVVLAFFVVQ | 1006 | Q14703 | |
| QNPIVFMVFIGIAFN | 216 | Q7Z3F1 | |
| FMVFIGIAFNFILDR | 221 | Q7Z3F1 | |
| FFNSFQENGRLFIVM | 66 | Q6P3R8 | |
| FIINLFVMAVFGQAF | 296 | P49279 | |
| FIILAFVMNSVAFIG | 981 | Q92887 | |
| FVVFSVIYINAMIGN | 26 | Q8NGP0 | |
| NFLMVFIFAGSVQVF | 211 | Q8NGV6 | |
| INALMIFIFGAFIQI | 196 | Q9NZP5 | |
| VSLFFMFIGFILNNI | 106 | Q9UF02 | |
| IIIAFFMMNIFVGFV | 1171 | Q13936 | |
| FMMNIFVGFVIVTFQ | 1176 | Q13936 | |
| FFVLNMFVGVVVENF | 1526 | O43497 | |
| MAFFFIFGAQFVLTV | 106 | Q969E2 | |
| LQIFSKNFEMFVVLF | 186 | O76082 | |
| LGTEFQVMFFFSALV | 211 | Q9UMX9 | |
| IIIVAFFMMNIFVGF | 1136 | Q01668 | |
| FNNIYGIAVAMFIVV | 196 | Q8NGK4 | |
| FNNIYGIAVAMFIVV | 196 | Q8NGK3 | |
| HFFSLQVANGIFFML | 246 | Q7RTR8 | |
| FLQGVAAVFMFAFAS | 11 | Q9BU23 | |
| FREAQMTIFGVLFKF | 1116 | Q8NE09 | |
| GLIFAFANAVAVAMY | 261 | Q13621 | |
| GASFVFVTMILFVAN | 136 | Q8NCR9 | |
| VMNFFEEVFIYIGNI | 561 | Q7RTR0 | |
| FNIIIIFLMFFNTFV | 51 | Q9NPI0 | |
| IFLMFFNTFVFQAGL | 56 | Q9NPI0 | |
| MTFEAQAFLEAVQFF | 206 | Q9BZQ8 | |
| MLQIGNIVFTIFFTA | 696 | Q9Y5Y9 | |
| IFAFANAVAVAMYVV | 371 | P55011 | |
| DIVGFAIMFFIIFFA | 406 | Q9NZM6 | |
| FFVFFVLLNMFLAII | 476 | Q9NZM6 | |
| DILGFAVMFFIVFFA | 476 | Q9P0L9 | |
| FFVFFVLLNMFLAII | 546 | Q9P0L9 | |
| INGLFLIVIAFFVFM | 491 | Q8TAD4 | |
| NGIIFLFVLANFSMA | 51 | Q9ULC8 |